How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

2 months ago
Clinical Development,Clinical Operations,News

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

2 months ago

Weekly News Round-up – 11/9/20

In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...

3 months ago
Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 11/9/20

In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...

3 months ago

Overcoming the Challenges of Decentralised Trials

Decentralised trials - clinical trials with virtual or online elements - have a huge number of advantages in the trial space. They are cheaper, faster, and allow for greater safety and recruitment of patients. But so far they have yet...

3 months ago
Clinical Development,Clinical Operations,News

Overcoming the Challenges of Decentralised Trials

Decentralised trials - clinical trials with virtual or online elements - have a huge number of advantages in the trial space. They are cheaper, faster, and allow for greater safety and recruitment of patients. But so far they have yet...

3 months ago

Weekly News Round-Up – 14/8/20

In the news this week, the race for a vaccine begins to near its conclusion as the U.S. and U.K. continue to buy up supplies of promising vaccines, and Moderna comes under criticism for its steep prices that make the...

4 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 14/8/20

In the news this week, the race for a vaccine begins to near its conclusion as the U.S. and U.K. continue to buy up supplies of promising vaccines, and Moderna comes under criticism for its steep prices that make the...

4 months ago

The Future of Clinical Trials and Pharmacovigilance

This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Clinical Trials/Pharmacovigilance...

4 months ago
Pharmacovigilance,Clinical Development,Clinical Operations,News

The Future of Clinical Trials and Pharmacovigilance

This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Clinical Trials/Pharmacovigilance...

4 months ago

Weekly News Round-up – 7/8/20

In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...

4 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 7/8/20

In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...

4 months ago

Personalised Medicine Strategies – Providing More Clinical Benefit

Current personalised medicine strategies provide limited clinical benefit – how do we do better? Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here's another chance to watch...

4 months ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine

Personalised Medicine Strategies – Providing More Clinical Benefit

Current personalised medicine strategies provide limited clinical benefit – how do we do better? Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here's another chance to watch...

4 months ago

Weekly News Round-up – 17/7/20

In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...

5 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 17/7/20

In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...

5 months ago

Weekly News Round-up – 10/7/20

In the news this week, the Trump Administration has made another deal to acquire all initial doses of a potential COVID-19 drug, in this case Regeneron’s REGN-COV2. This follows their acquisition of the first batches of Gilead’s remdesivir last week....

5 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 10/7/20

In the news this week, the Trump Administration has made another deal to acquire all initial doses of a potential COVID-19 drug, in this case Regeneron’s REGN-COV2. This follows their acquisition of the first batches of Gilead’s remdesivir last week....

5 months ago

Clinical Trial Continuity and the Impact of COVID-19

Here's a second chance to catch the fascinating keynote panel discussion lead by Josh Rose, VP GM Virtual Trial Solutions Business, IQVIA and joined by Eli Lilly and Co., EMD Serono/Merck KGaA and Janssen. See how you can prepare for...

5 months ago
Clinical Development

Clinical Trial Continuity and the Impact of COVID-19

Here's a second chance to catch the fascinating keynote panel discussion lead by Josh Rose, VP GM Virtual Trial Solutions Business, IQVIA and joined by Eli Lilly and Co., EMD Serono/Merck KGaA and Janssen. See how you can prepare for...

5 months ago